99mTc-MIRC208

N/A

Report date: 2025/09/24 16:01:10

Base Information

Drug Name99mTc-MIRC208

Drug Alias NameN/A

ClassificationRadiation-emitting products > Radioactive diagnostic agentBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)Radiation-emitting products > Nuclides > Technetium > 99mTc +[4]

Mechanisms of ActionSingle-photon emission-computed tomography enhancers

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaClinical

Originator CompaniesBeijing Cancer Hospital

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Cancer Hospital

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A